hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06350266, orgStudyIdInfo id: 2024-0183, briefTitle: Informing Low-acuity Emergency Department Patients of Non-emergent Resources, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-22, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Geisinger Clinic, class: OTHER, descriptionModule briefSummary: The goal of this campaign is to reduce unnecessary ED visits/encourage patients with low acuity visits to follow up with an appropriate provider and/or to seek care outside of the ED in the future. In this campaign, patients will be assigned to receive or not receive outreach following ED discharge that is aligned with the goal. Outreach will occur via a text message, as well as information added to the patient's after visit summary, and will include one or more calls to action that make patients aware of other Geisinger resources and avenues through which they can seek care outside of the ED. These may include, but are not limited to, walk-in urgent care, virtual urgent care, PCP appointments, and/or other ways in which to contact Geisinger. We will measure whether ED use differs across patients in different outreach conditions. We will also examine whether patients followed through on the message-specific calls to action in the messages differently across conditions., conditionsModule conditions: Emergency Service, Hospital, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, maskingDescription: Patients will be aware of their own messages but not of messages sent to other patients or in other arms., enrollmentInfo count: 8300, type: ESTIMATED, armsInterventionsModule interventions name: Information about healthcare resources, outcomesModule primaryOutcomes measure: Return to ED, otherOutcomes measure: PCP appointment scheduled, otherOutcomes measure: PCP visit, otherOutcomes measure: Telehealth appointment scheduled, otherOutcomes measure: Telehealth appointment attended, otherOutcomes measure: Urgent care visit, otherOutcomes measure: Call made to PCP, otherOutcomes measure: Any of the suggested actions taken, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06350253, orgStudyIdInfo id: 22-X-187, briefTitle: Comparison Of Measured To Predicted Resting Metabolism, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-03-14, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Ohio University, class: OTHER, descriptionModule briefSummary: The purpose of this study is to compare RMR values from the BIA, predicted equations, and indirect calorimetry., conditionsModule conditions: Body Weight, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 150, type: ESTIMATED, armsInterventionsModule interventions name: Metabolic cart, interventions name: MedGem, interventions name: BIA, outcomesModule primaryOutcomes measure: Resting metabolic rate, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Ohio University Exercise Physiology Lab, status: RECRUITING, city: Athens, state: Ohio, zip: 45701, country: United States, contacts name: Angela Hillman, PhD, role: CONTACT, phone: 740-593-0153, email: hillman@ohio.edu, geoPoint lat: 39.32924, lon: -82.10126, hasResults: False
protocolSection identificationModule nctId: NCT06350240, orgStudyIdInfo id: KUzunAkkaya, briefTitle: Effects of Textured Insoles and Exercise in Children With Joint Hypermobility, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-01, primaryCompletionDateStruct date: 2024-11-01, completionDateStruct date: 2024-11-30, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Gazi University, class: OTHER, collaborators name: TÜBİTAK, descriptionModule briefSummary: Joint hypermobility is the condition that the joints have a greater range of motion than normal and can be observed frequently in children. In children with joint hypermobility, motor problems, tactile and proprioceptive sensory disorders can be observed. It is very important to support children with joint hypermobility with intervention programs that are rich in both motor and sensory aspects. The aim of this project is to create an exercise protocol rich in tactile, proprioceptive senses for children with joint hypermobility and to examine the effects of using textured insoles in addition to exercise on tactile sense, balance, foot load distribution and quality of life in children., conditionsModule conditions: Child, Only, conditions: Joint Laxity, conditions: Exercise, conditions: Textured Insoles, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: INVESTIGATOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Exercise, interventions name: Exercise+texture insoles, outcomesModule primaryOutcomes measure: Tactile sense, primaryOutcomes measure: Foot load distribution, primaryOutcomes measure: Balance, secondaryOutcomes measure: Foot posture, secondaryOutcomes measure: Quality of life assessment, eligibilityModule sex: ALL, minimumAge: 5 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Gazi University, status: RECRUITING, city: Ankara, country: Turkey, contacts name: Kamile Uzun Akkaya, Phd, role: CONTACT, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06350227, orgStudyIdInfo id: WestChinaSU, briefTitle: Impact of Different Hemostasis Methods on Ovarian Function and Fertility During Laparoscopic Ovarian Cystectomy of Benign Ovarian Cyst, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-04, primaryCompletionDateStruct date: 2026-01, completionDateStruct date: 2026-06, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: West China Second University Hospital, class: OTHER, descriptionModule briefSummary: The purpose of this study is to compare the impact of different hemostasis methods during laparoscopic ovarian cystectomy on ovarian function and fertility in women with benign ovarian cysts., conditionsModule conditions: Ovarian Cyst Benign, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 165, type: ESTIMATED, armsInterventionsModule interventions name: the absorbable hemostat and suture, interventions name: electrocoagulation and suture, interventions name: suture, outcomesModule primaryOutcomes measure: Antral Follicle Count (AFC), secondaryOutcomes measure: Anti-Mullerian hormone (AMH), eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: West China Second University Hospital, Sichuan University, status: RECRUITING, city: Chengdu, state: Sichuan, country: China, contacts name: Yanru Long, role: CONTACT, phone: 86-13550169017, email: 2801443341@qq.com, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06350214, orgStudyIdInfo id: #2005-06; #2011-17; #2018-01, briefTitle: Physical Activity and Nutrition in Cancer Survivors, statusModule overallStatus: COMPLETED, startDateStruct date: 2007-01-01, primaryCompletionDateStruct date: 2018-12-31, completionDateStruct date: 2018-12-31, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: West China Hospital, class: OTHER, descriptionModule briefSummary: This study aims to investigate the independent and combined associations between physical activity and nutrition condition with mortality among cancer survivors., conditionsModule conditions: Cancer, conditions: Nutrition, Healthy, conditions: Physical Inactivity, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 3100, type: ACTUAL, armsInterventionsModule interventions name: physical activity and nutrition assessment, outcomesModule primaryOutcomes measure: All-cause mortality, primaryOutcomes measure: Cause-specific mortality, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06350201, orgStudyIdInfo id: KY2024.0124.02, briefTitle: Machine Learning-based Classification of Symptom Clusters and Online CBT, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-12-01, completionDateStruct date: 2024-12-01, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Wuhan Mental Health Centre, class: OTHER, descriptionModule briefSummary: To breakthrough the bottleneck identified, we will conduct a cross-sectional study to develop a symptom clustering model for depression and anxiety. A wide range of statistical methods as well as machine learning approaches were explored, and a cohesive hierarchical clustering algorithm will be used. After developing the model, a symptom-matched intervention program based on problem solving therapy will be formulated. We are supposed to examine whether its use for personalizing symptom-matched psychological treatment can lead to improved patient outcomes, compared with usual care. This project is expected to provide a new and precise method for the emotion management, which will provide a standardized intervention pathway combining screening with treatment for the management of depression symptom and anxiety symptom. A preciser intervention matched to individual symptoms may provide important insight in improving patient outcome as well as a standardized mood management pathway targeting to the early detection and intervention for community residents., conditionsModule conditions: Depression and Anxiety Symptom, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: cognitive behavior therapy, interventions name: control group, outcomesModule primaryOutcomes measure: The Patient Health Questionnaire (PHQ-9), secondaryOutcomes measure: 7-tiem Generalized Anxiety Disorder Scale,GAD-.7, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06350188, orgStudyIdInfo id: ECM#2024-506, briefTitle: Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-03-22, primaryCompletionDateStruct date: 2024-06-22, completionDateStruct date: 2024-07-22, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: purpose of the study To investigate the effect of Kinesio-tape on treatment of nonspecific cardiac chest pain, conditionsModule conditions: Nonspecific Cardiac Chest Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: experimental, interventions name: traditional, outcomesModule primaryOutcomes measure: PAIN USING VIISUSL ANALOGE SCALE, secondaryOutcomes measure: PERSSURE PAIN THRESHOLD, otherOutcomes measure: SHOULDER RANGE OF MOTION, otherOutcomes measure: shoulder pain and disability, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Huda Badr Abd Elhamed, city: Cairo, country: Egypt, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06350175, orgStudyIdInfo id: 2212697123, briefTitle: Emergency Department Management of Tobacco Use Disorder, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: West Virginia University, class: OTHER, descriptionModule briefSummary: The objective of this study is to determine the effectiveness of ED initiated NRT on tobacco cessation point abstinence rates as reported by patients at 2 weeks and 1 month post randomization, and continued abstinence rates at 3 months compared to standard of care therapy., conditionsModule conditions: Tobacco Use Disorder, conditions: Tobacco Use Cessation, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: INVESTIGATOR, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Nicotine Replacement Therapy Agent, interventions name: West Virginia Quit Line, outcomesModule primaryOutcomes measure: Percentage of Continued Abstinence Rate (2 weeks), primaryOutcomes measure: Percentage of Continued Abstinence Rate (1 month), primaryOutcomes measure: Percentage of Continued Abstinence Rate (3 months), primaryOutcomes measure: Patient Health Questionnaire 2 (Baseline), primaryOutcomes measure: Patient Health Questionnaire 2 (3 months from baseline), primaryOutcomes measure: Heaviness of Smoking Index (Baseline), primaryOutcomes measure: Heaviness of Smoking Index (3 months from baseline), primaryOutcomes measure: Richmond Test (Baseline), primaryOutcomes measure: Richmond Test (3 months from baseline), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: West Virginia University, city: Morgantown, state: West Virginia, zip: 26505, country: United States, geoPoint lat: 39.62953, lon: -79.9559, hasResults: False
protocolSection identificationModule nctId: NCT06350162, orgStudyIdInfo id: ASTRUM-LC12, briefTitle: Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-18, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Zhejiang Cancer Hospital, class: OTHER, descriptionModule briefSummary: This phase II trial compares the effect of adding radiation therapy to the usual maintenance therapy with Serplulimab versus Serplulimab alone in patients who have already received Serplulimab plus chemotherapy for the treatment of extensive stage small cell lung cancer ., conditionsModule conditions: Extensive Stage Lung Small Cell Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Serplulimab, interventions name: Chest Radiation, outcomesModule primaryOutcomes measure: 1-year Progression-free survival rate, secondaryOutcomes measure: Progression-free survival (PFS), secondaryOutcomes measure: Overall survival (OS), secondaryOutcomes measure: Duration of response (DOR), secondaryOutcomes measure: Disease control rate (DCR), otherOutcomes measure: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Zhejiang Cancer Hospital, status: RECRUITING, city: Hangzhou, country: China, contacts name: jing Qin, role: CONTACT, geoPoint lat: 30.29365, lon: 120.16142, hasResults: False
protocolSection identificationModule nctId: NCT06350136, orgStudyIdInfo id: 2024/05-37, briefTitle: The Effect of Self-Management Support Provided to Hypertension Patients Affected by the Earthquake Via Tele-Nursing on Patients' Treatment Compliance and Self-Care Management, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2024-12-01, completionDateStruct date: 2025-06-01, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Firat University, class: OTHER, descriptionModule briefSummary: This important research includes a randomized controlled trial evaluating the potential of self-management support provided via telenursing to earthquake-affected hypertension patients to improve patients' treatment adherence and overall self-care management. This study will be carried out at Fırat University Hospital and will cover a wide range of effects on health outcomes in individuals receiving hypertension treatment. The sample selected from hypertension patients, which constitute the population of the research, was based on predetermined power analysis criteria. It has been determined that at least 51 hypertension patients should be included in each of the intervention and control groups, and accordingly, a total of 150 hypertension patients will be included in the study.. The results obtained within this framework may provide guidance in the development and implementation of Turkey's health policies, and may also shed light on strategies for the management of other similar health problems. On the other hand, strengthening the digital health infrastructure and effective management of chronic diseases, which are among the health-related targets of the Development Plan, further emphasize the importance of this research. The success of the self-management model supported by tele-nursing can serve as an example in the integration of digital health technologies into Turkey's healthcare system and be an important step towards achieving strategic goals in this field., conditionsModule conditions: With Tele-Nursing, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 150, type: ESTIMATED, armsInterventionsModule interventions name: With Tele-Nursing, outcomesModule primaryOutcomes measure: Hill-Bone Hypertension Treatment Compliance Scale, primaryOutcomes measure: Self-Care Management Scale in Chronic Diseases;, primaryOutcomes measure: Psychological Impact of Earthquake Scale:, primaryOutcomes measure: Earthquake Stress Coping Strategies Scale, eligibilityModule sex: ALL, minimumAge: 55 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06350110, orgStudyIdInfo id: ESBI202492, briefTitle: Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE), acronym: BAH242, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-11-10, primaryCompletionDateStruct date: 2025-12-10, completionDateStruct date: 2025-12-28, studyFirstPostDateStruct date: 2024-04-05, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Essen Biotech, class: OTHER, descriptionModule briefSummary: This study is a preliminary investigation, with a single-group design, not randomized and transparent, focusing on treatment. Its purpose is to identify the highest dose of BH002 injection (CD19-BCMA CAR-T cells) that patients suffering from resistant systemic lupus erythematosus can tolerate., conditionsModule conditions: Systemic Lupus Erythematosus, conditions: Lupus Nephritis, conditions: Autoimmune Diseases, conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, conditions: Granulomatous Polyangiitis, conditions: Microscopic Polyangiitis, conditions: Systemic Sclerosis, conditions: Idiopathic Inflammatory Myopathies, conditions: Sjogren's Syndrome, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Single Group AssignmentPatients enrolled in this clinical trial will receive a carefully designed treatment regimen. Prior to the infusion of CD19 and BCMA CAR-T cells, participants will undergo preconditioning chemotherapy. This chemotherapy serves to create an optimal environment for the CAR-T cell therapy to effectively target and eliminate malignant B cells. Following chemotherapy, participants will receive the infusion of CD19 and BCMA CAR-T cells.Monitoring and Follow-up:Following the CAR-T cell infusion, patients will be subjected to rigorous monitoring to assess safety and treatment response., primaryPurpose: TREATMENT, maskingInfo masking: NONE, maskingDescription: Open-label clinical trials are a category of clinical research where the masking is minimal or nonexistent. In such trials, both the participants and the researchers are fully aware of the treatment assignments, which means participants know the treatment they are receiving, and researchers are aware of each participant's treatment group., enrollmentInfo count: 75, type: ESTIMATED, armsInterventionsModule interventions name: CD19- BCMA CAR-T cells, outcomesModule primaryOutcomes measure: Incidence and severity of dose limiting toxicities (DLTs) following chemotherapy preparative regimen and infusion of CD19/BCMA chimeric antigen receptor (CAR) T cells, secondaryOutcomes measure: Rate of successful manufacture and expansion of the CD19/BCMA chimeric antigen receptor (CAR) T cells, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 90 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: District one hospital, city: Shanghai, country: China, geoPoint lat: 31.22222, lon: 121.45806, hasResults: False